Mayo Clinic Proceedings Home

Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross-Sectional Survey



      To evaluate the knowledge of and nature of training for menopause management in postgraduate residents.

      Participants and Methods

      A cross-sectional, anonymous survey was e-mailed to trainees at all postgraduate levels in family medicine, internal medicine, and obstetrics and gynecology at US residency programs between January 11, and July 4, 2017. The survey was adapted from an existing instrument and included questions regarding knowledge of hormone therapy (HT) and other menopause management strategies, availability and type of training in menopause medicine, and demographic information.


      Of the 703 surveys sent, a total of 183 residents representing 20 US residency programs responded (26.0% response rate). Most trainees were between 26 and 30 years of age (133 of 172 [77.3%]), female (114 of 173 [65.9%]), and believed it was important or very important to be trained to manage menopause (165 of 176 [93.8%]). Although most respondents answered some of the menopause competency questions correctly, important gaps were identified. Of 183 participants, 63 (34.4%) indicated they would not offer HT to a symptomatic, newly menopausal woman without contraindications, and only 71 (38.7%) indicated they would prescribe HT until the natural age of menopause to a prematurely menopausal woman. Of 177 respondents, 36 (20.3%) reported not receiving any menopause lectures during residency, and only 12 of 177 (6.8%) reported feeling adequately prepared to manage women experiencing menopause.


      Family medicine, internal medicine, and obstetrics and gynecology residency trainees recognize the importance of training in menopause management, but important knowledge gaps exist. Investing in the education of future clinicians to provide evidence-based, comprehensive menopause management for the growing population of midlife women is a priority.

      Abbreviations and Acronyms:

      FM (family medicine), HT (hormone therapy), IM (internal medicine), NAMS (North American Menopause Society), OB/GYN (obstetrician-gynecologist), PGY (postgraduate year), VMS (vasomotor symptoms), WHI (Women's Health Initiative)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • NAMS 2017 Hormone Therapy Position Statement Advisory Panel
        The 2017 hormone therapy position statement of The North American Menopause Society.
        Menopause. 2017; 24: 728-753
        • Sarrel P.
        • Portman D.
        • Lefebvre P.
        • et al.
        Incremental direct and indirect costs of untreated vasomotor symptoms.
        Menopause. 2015; 22: 260-266
        • Tan W.Y.
        • Grothe D.
        • Keshishian A.
        • Morgenstern D.
        • Haider S.
        Pharmacoecnomic and associated cost savings among women who were prescribed systemic conjugated estrogens therapy compared with those without menopausal therapy.
        Menopause. 2017; 25: 493-499
        • Manson J.E.
        • Kaunitz A.M.
        Menopause management—getting clinical care back on track.
        N Engl J Med. 2016; 374: 803-806
        • Carr B.R.
        • Wilson J.D.
        Disorders of the ovary and female reproductive tract.
        in: Isselbacher K.J. Braunwald E. Wilson J.D. Martin J.B. Fauci A.S. Kasper D.L. Harrison's Principles of Internal Medicine. 13th ed. McGraw-Hill, New York, NY1994: 2016-2017
        • Davidson M.H.
        • Maki K.C.
        • Marx P.
        • et al.
        Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausel women.
        Arch Intern Med. 2000; 160: 3315-3325
        • Grodstein F.
        • Manson J.E.
        • Colditz G.A.
        • Willett W.C.
        • Speizer F.E.
        • Stampfer M.J.
        A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
        Ann Intern Med. 2000; 133: 933-941
        • Grady D.
        • Rubin S.M.
        • Petitti D.B.
        • et al.
        Hormone therapy to prevent disease and prolong life in postmenopausal women.
        Ann Intern Med. 1992; 117: 1016-1037
        • Steinkellner A.R.
        • Denison S.E.
        • Eldridge S.L.
        • Lenzi L.L.
        • Chen W.
        • Bowlin S.J.
        A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative.
        Menopause. 2012; 19: 616-621
        • Rossouw J.E.
        • Anderson G.L.
        • Prentice R.L.
        • et al.
        • Writing Group for the Women's Health Initiative Investigators
        Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.
        JAMA. 2002; 288: 321-333
        • Majumdar S.R.
        • Almasi E.A.
        • Stafford R.S.
        Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.
        JAMA. 2004; 292: 1983-1988
        • Tsai S.A.
        • Stefanick M.L.
        • Stafford R.S.
        Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009.
        Menopause. 2011; 18: 385-392
        • Santen R.J.
        • Allred D.C.
        • Ardoin S.P.
        • et al.
        Postmenopausal hormone therapy: an Endocrine Society scientific statement.
        J Clin Endocrinol Metab. 2010; 95: S1-S66
        • North American Menopause Society
        The 2012 hormone therapy position statement of The North American Menopause Society.
        Menopause. 2012; 19: 257-271
        • de Villiers T.J.
        • Gass M.L.
        • Haines C.J.
        • et al.
        Global consensus statement on menopausal hormone therapy.
        Climacteric. 2013; 16: 203-204
        • Rossouw J.E.
        • Manson J.E.
        • Kaunitz A.M.
        • Anderson G.L.
        Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
        Obstet Gynecol. 2013; 121: 172-176
        • Manson J.E.
        • Chlebowski T.R.
        • Stefanick M.L.
        • et al.
        Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
        JAMA. 2013; 310: 1353-1368
        • Manson J.E.
        • Argaki A.K.
        • Rossouw J.E.
        • et al.
        WHI Investigators. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials.
        JAMA. 2017; 318: 927-938
        • Stuenkel C.A.
        • Davis S.R.
        • Gompel A.
        • et al.
        Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline.
        J Clin Endocrinol Metab. 2015; 100: 3975-4011
        • American College of Obstetricians and Gynecologists
        ACOG Practice Bulletin No. 141: Management of menopausal symptoms.
        Obstet Gynecol. 2014; 123: 202-216
        • Santen R.J.
        • Stuenkel C.A.
        • Burger H.G.
        • Manson J.E.
        Competency in menopause management: whither goest the internist?.
        J Womens Health (Larchmt). 2014; 23: 281-285
        • Cumming G.P.
        • Curie H.
        • Morris E.
        • Moncur R.
        • Lee A.J.
        The need to do better – are we still letting our patients down and at what cost?.
        Post Reprod Health. 2015; 21: 56-62
        • Hsieh E.
        • Nunez-Smith M.
        • Henrich J.B.
        Needs and priorities in women's health training: perspectives from an internal medicine residency program.
        J Womens Health (Larchmt). 2012; 22: 667-672
        • Casas R.S.
        • Hallett L.D.
        • Rich C.A.
        • Gerber M.R.
        • Battaglia T.A.
        Program directors' perceptions of resident education in women's health: a national survey.
        J Womens Health (Larchmt). 2017; 26: 133-140
        • Hess R.
        • Chang C.C.
        • Conigliaro J.
        • McNeil M.
        Understanding physicians' attitudes towards hormone therapy.
        Womens Health Issues. 2005; 15: 31-38
        • Christianson M.S.
        • Washington C.I.
        • Stewart K.I.
        • Shen W.
        Effectiveness of a 2-year menopause medicine curriculum for obstetrics and gynecology residents.
        Menopause. 2015; 23: 275-279
        • Newton K.M.
        • LaCroix A.Z.
        • Buist D.S.
        • Anderson L.A.
        • Delaney K.
        What factors account for hormone replacement therapy prescribing frequency?.
        Maturitas. 2001; 39: 1-10
        • Faubion S.S.
        Mayo Clinic The Menopause Solution: A Doctor's Guide to: Relieving Hot Flashes, Enjoying Better Sex, Sleeping Well, Controlling Your Weight, and Being Happy.
        Time Inc Books, New York, NY2016
      1. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society.
        Menopause. 2015; 22: 1155-1172
        • de Villiers T.J.
        • Hall J.E.
        • Pinkerton J.V.
        • et al.
        Revised global consensus statement on menopausal hormone therapy.
        Climacteric. 2016; 19: 313-315
        • Rocca W.A.
        • Gazzuola Rocca L.
        • Smith C.Y.
        • et al.
        Bilateral oophorectomy and accelerated aging: cause or effect?.
        J Gerontol A Biol Sci Med Sci. 2017; 72: 1213-1217
        • Shuster L.T.
        • Gostout B.S.
        • Grossardt B.R.
        • Rocca W.A.
        Prophylactic oophorectomy in premenopausal women and long-term health – a review.
        Menopause Int. 2008; 14: 111-116
        • Faubion S.S.
        • Kuhle C.L.
        • Shuster L.T.
        • Rocca W.A.
        Long-term health consequences of premature or early menopause and considerations for management.
        Climacteric. 2015; 18: 483-491
        • Parker W.H.
        • Feskanich D.
        • Broder M.S.
        • et al.
        Long-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses' Health Study.
        Obstet Gynecol. 2013; 121: 709-716
        • Taylor H.S.
        • Kagan R.
        • Altomare C.J.
        • Cort S.
        • Bushmakin A.G.
        • Abraham L.
        Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
        Menopause. 2017; 24: 27-34
        • Kaunitz A.M.
        • Manson J.E.
        Management of menopausal symptoms.
        Obstet Gynecol. 2015; 126: 859-876
        • Jiang X.
        • Schnatz P.F.
        Menopausal medicine: how to educate the next generation of menopause clinicians [editorial].
        Menopause. 2013; 20: 1109-1110
        • Freeman E.W.
        • Sammel M.D.
        • Lin H.
        • et al.
        Symptoms associated with menopausal transition and reproductive hormones in midlife women.
        Obstet Gynecol. 2007; 110: 230-240
        • Dugan S.A.
        • Powell L.H.
        • Kravitz H.M.
        • Everson Rose S.A.
        • Karavolos K.
        • Luborsky J.
        Musculoskeletal pain and menopausal status.
        Clin J Pain. 2006; 22: 325-331
        • Baber R.
        Teaching the teachers [editorial].
        Climacteric. 2017; 20: 503-504
        • US Preventive Services Task Force
        Clinical summary: hormone therapy in postmenopausal women: primary prevention of chronic conditions.
        (US Preventive Services Task Force website) (Published December 2017. Accessed January 3, 2018)
        • Kling J.M.
        • Rose S.H.
        • Kransdorf L.N.
        • Viggiano T.R.
        • Miller V.M.
        Evaluation of sex- and gender-based medicine training in post-graduate medical education: a cross-sectional survey study.
        Biol Sex Differ. 2016; 7: 38
        • Momin M.
        • Miloro M.
        • Mercuri L.G.
        • Munaretto A.
        • Markiewicz M.R.
        Senior oral and maxillofacial surgery resident confidence in performing invasive temporomandibular joint procedures.
        J Oral Maxillofac Surg. 2017; 75: 2091.e1-2091.e10
        • Mazzola C.A.
        • Lobel D.A.
        • Krishnamurthy S.
        • Bloomgarden G.M.
        • Benzil D.L.
        Efficacy of neurosurgery resident education in the new millennium: the 2008 Council of State Neurosurgical Societies post-residency survey results.
        Neurosurgery. 2010; 67: 225-232
        • Daugherty S.R.
        • Baldwin Jr., D.C.
        • Rowley B.D.
        Learning, satisfaction, and mistreatment during medical internship: a national survey of working conditions.
        JAMA. 1998; 279: 1194-1199

      Linked Article

      • Barriers to the Care of Menopausal Women
        Mayo Clinic ProceedingsVol. 94Issue 2
        • Preview
          Barriers to care fall into 2 general categories: knowledge gaps and implementation gaps.1 The art of medicine rests on the practitioner understanding what is and is not known, recognizing the limitations of our evidence and interventions, and then developing an informed and affordable therapeutic approach that a specific patient is able and willing to follow. Given that physicians are treating patients and not conditions per se and that the patient’s condition occurs in the context of multiple other medical and sociocultural modifiers, it takes experience to become an artful physician who can walk from generalization (fund of knowledge) to individualization (application of the fund of knowledge).
        • Full-Text
        • PDF